Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression

Author： Paschos Konstantinos A.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.23, Iss.9, 2009-09, pp. : 755-772

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

By Holmes A.   Heilig M.   Rupniak N.M.J.   Steckler T.   Griebel G.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 11, 2003-11 ,pp. : 580-588

Elsevier

Access to resources Recommend Favorite

Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment

By  

Current Neuropharmacology, Vol. 12, Iss. 2, 2014-03 ,pp. : 108-119

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid Receptors as Therapeutic Targets

By  

Current Pharmaceutical Design, Vol. 12, Iss. 14, 2006-05 ,pp. : 1751-1769

Bentham Science Publishers

Access to resources Recommend Favorite

Sigma receptors: biology and therapeutic potential

By Guitart Xavier   Codony Xavier   Monroy Xavier  

Psychopharmacology, Vol. 174, Iss. 3, 2004-07 ,pp. : 301-319

Springer Publishing Company

Access to resources Recommend Favorite

Neuropeptide Y receptors as targets of obesity treatment

By Ishihara PhD Akane   Moriya PhD Minoru   MacNeil PhD Douglas J   Fukami PhD Takehiro   Kanatani PhD Akio  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 12, 2006-12 ,pp. : 1701-1712

Informa Healthcare

Access to resources Recommend Favorite